XML 17 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2017   8,662,435      
Beginning balance at Dec. 31, 2017 $ 35,216 $ 9 $ 381,199 $ (134) $ (345,858)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon vesting of restricted stock units (in shares)   8,660      
Stock-based compensation expense 1,627   1,627    
Issuance of common stock upon exercise of options (in shares)   328      
Issuance of common stock upon exercise of options 1   1    
Issuance of common stock under Employee Stock Purchase Plan (in shares)   21,377      
Issuance of common stock under Employee Stock Purchase Plan 207   207    
Unrealized gain on short-term investments 7     7  
Net loss (16,025)       (16,025)
Ending balance (in shares) at Mar. 31, 2018   8,692,800      
Ending balance at Mar. 31, 2018 22,876 $ 9 383,034 (127) (360,040)
Beginning balance (in shares) at Dec. 31, 2018   8,818,019      
Beginning balance at Dec. 31, 2018 (5,854) $ 9 386,860 0 (392,723)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon vesting of restricted stock units (in shares)   93,648      
Stock-based compensation expense 959   959    
Issuance of common stock under Employee Stock Purchase Plan (in shares)   2,369      
Issuance of common stock under Employee Stock Purchase Plan 2   2    
Issuance of common stock upon sales using ATM (in shares)   1,903,880      
Issuance of common stock upon sales using ATM 2,084 $ 2 2,082 0 0
Net loss (3,260)       (3,260)
Ending balance (in shares) at Mar. 31, 2019   10,817,916      
Ending balance at Mar. 31, 2019 $ (6,069) $ 11 $ 389,903 $ 0 $ (395,983)